Gary Taubes vs Stephan Guyenet on Joe Rogan Podcast
If you haven't yet seen the Gary Taubes vs Stephan Guyenet showdown on Joe Rogan's podcast last week, none of this will make any sense. I’d like to give my thoughts on the Stephen Guyenet vs Gary Taubes debate on the Joe Rogan podcast. I know everyone is tired of this discussion, so hopefully, I bring something new that you haven’t heard yet. Here goes. Initially, I expected Stephan to wipe the floor with Taubes. I did. I understand the importance of calories, and I think the carb-insulin...

“Taubes is arguing with stories.” Even if his conclusions and theories are dubious, way to expertly diminish the fact that his gift is in poking holes and pointing out that there is something wrong with the current paradigm on the causes of obesity. “Stephan was an arrogant asshole.” Who gives a shit.
Stephan has so much information he could be dressed as a unicorn wearing hot pink lipstick and making horse noises, and you’d be an idiot not to move past that fact and consider everything he says carefully. If you have the best brain surgeon in the world operating on your brain tumor but his bedside manner sucks, are you going to find someone else to perform the surgery who is “nice?”
But to avoid my own hypocrisy in writing this post, I’m going to be goal-oriented here as I wish they had been.How Taubes and Guyenet Were Both Right and Wrong in My Estimation
First, it is clear to me that both Taubes and Stephan were both right and wrong. Second, it is clear to me that we are missing some big piece which makes them both right. Third, I’ve said this a million times since 2012, everyone needs to take a seat and chill the f out until we work out the kinks and nuances of the gut microbiome. As far as the gut microbiome is concerned, thus far we understand that: • Microbiota produce metabolites and microbial products like lipopolysaccharides (LPS) • Lipopolysaccharides (or endotoxins) are part of the outer membrane of Gram-negative bacteria. • In gut dysbiosis featuring more gram-negative bacteria, more LPS is presented. • LPS stimulates the production of inflammatory cytokines within the central nervous system, especially the pineal gland that produces melatonin (more on that in a bit) • LPS can modulate appetite, energy uptake, storage, and energy expenditure. • LPS shifts post-prandial plasma ghrelin to *fasted levels.* (in case you would like a mechanism for how gut dysbiosis itself can lead to overeating) • LPS promotes leptin resistance • LPS down-regulates the expression of neuropeptide proglucagon • LPS inhibits expression of gut-secreted GLP-1 and PYY (so increases food intake, and anxiety and depression-related behavior) (Sidebar: while some specialists see the link between depression and weight gain but have no idea what to attribute that to, there’s a possible clue!) • LPS increases serum cholesterol levels by increasing hepatic cholesterol synthesis ( sidebar, that production is hepatoprotective from low-grade endotoxemia) • LPS influences metabolic endotoxemia, initiating obesity and insulin resistance • LPS causes an increase in intestinal tight junction permeability.Speaking of Permeability, We Also Currently Understand That:
• Intestinal permeability and adipose tissue inflammation have long been considered mechanistic links in the relationship between diet, obesity, and chronic metabolic disease. • Intestinal permeability influences the translocation of LPS. • The translocation of LPS also influences adipokine secretion and adipocyte hypertrophy. • Gut permeability and LPS influence visceral fat mass and intra-abdominal fat mass. • Gut permeability increases systemic inflammation.Speaking of Inflammation, We Also Currently Understand That:
• LPS influences inflammation, which in turn pings the positive-feedback loop for inflammation involving TRPV 1 pancreatic receptor. • Inflammation up-regulates the production of insulin (ps insulin is an anti-inflammatory hormone for all you insulin haters) • Inflammation up-regulates the production of cortisol. • Cortisol is a sterol, which is a subgroup of steroids that has oxygen at the end of the molecule. • Clinically significant gram-negative bacteria genera that produce LPS are all anaerobic. • Anaerobic bacteria cannot live or reproduce when oxygen is present. • Vitamin D, orange juice, and melatonin can cool LPS inflammation (this is an important clue).Speaking of Anaerobic Bacteria That Cannot Live or Reproduce in the Presence of Oxygen, We Also Understand Thus Far That:
• LPS induces the production of reactive oxygen species. • Reactive oxygen species (ROS) are used by LPS-producing bacteria to suppress the growth of competitors. • The production of oxygen-based radicals, ROS, is the bane of all aerobic species. • The detoxification of reactive oxygen species is paramount to the survival of all aerobic life forms. • ROS have a role in cell signaling, including apoptosis and gene expression. • The accumulation of reactive oxygen species plays a role in many pathologies, especially neuropathologies. • There is a long-established connection between low vitamin D and a wide range of metabolic and inflammatory diseases. • Increasing Vitamin D intake can reduce inflammation in the body. • Vitamin D is made from cholesterol, and the activated form of Vitamin D is a sterol. • Sterols are a subgroup of steroids that have oxygen at the end of the molecule. • Orange juice consumption with a high-fat, high-carbohydrate meal prevents post-prandial increases in LPS concentration. • Orange juice contains terpenoids. • Terpinoids are a class of naturally occurring organic chemicals with oxygen-containing functional groups. • The role of the pineal gland’s main hormone, melatonin, plays a role in the regulation of ghrelin synthesis. • The surgical removal of the pineal gland (and subsequent production of melatonin) results in weight gain, fatigue, and sadness. • The role of melatonin also plays an important role in leptin and MC4R regulation. • Of the anorexigenic signals, leptin plays a vital role as a satiety molecule. • Melatonin significantly reduces food intake. • Melatonin also reduces hormone signaling from ghrelin, and neuropeptide Y (NPY)(aka the most potent central enhancer of appetite). • The long-term absence of melatonin leads to leptin resistance. • Melatonin decreases LPS-induced blood-brain-barrier disruption. • Melatonin, as well as its metabolites, is effective in scavenging a variety of ROS. • Melatonin also significantly increases oxygen saturation compared to basal measurements in trials (which is often seen as an effect with low clinical significance.) Question: is it possible that the mechanism that makes Vitamin D and Melatonin so important to our health is simply a function of increasing oxygen saturation, thereby making the environment more aerobic and thus less hospitable to LPS producing anaerobes while improving the environment for our symbiotic aerobic bacteria?Full Circle
It is also well-known that the physiological control of appetite in animals is regulated by a complex interplay between hormones, neurotransmitters, and neuropeptides that interact reciprocally both at the central and peripheral level to stimulate or inhibit feeding behavior. Perhaps we recognize that there is a microbial event influencing all of the outcomes mentioned above. Maybe therein lies a missing piece which made Stephan Guyenet and Gary Taubes both correct. Now it’s time to come full circle with it. Thus far, we also understand that: • The microbiota is influenced by several factors including diet, use of antibiotics, hygiene, and genetics. • Different populations of peoples have vastly different microbiotic profiles, and thus, may respond differently to different diets. • Microbiomes influence the ‘healthy,’ or ‘unhealthy’ nature of foods on an individual basis (ahem, tomatoes). • Gut dysbiosis and improving intestinal permeability are relevant targets for both the prevention and reversal of weight gain. • People with weight loss resistance also tend to have a lower amount of Bacteroides, Verrucomicrobia, Faecalibacterium, and Prausnitzii and a higher amount of Actinobacteria and Firmicutes, and vice versa. • The two most abundant bacterial phyla in humans are Firmicutes and Bacteriodetes. • The ratio of Firmicutes to Bacteroides species will impact the efficiency of energy extraction, as well as changes in host metabolism, including absorbed calorie potential (hey-o) • The Low-carbohydrate, ketogenic diet lowers Firmicutes and raises Bacteroides. • A high-carbohydrate, high-fiber diet raises Firmicutes and lowers Bacteroides. Next, let's discuss the DIETFITS trial.
The year-long randomized clinical trial ( DIETFITS ) found that a low-fat, and low-carb diets produced similar weight loss and improvements in metabolic health markers — as a whole. The graphs, however, would tell a very different story if you looked at each line and each participant more carefully. Something very curious occurred, leaving us with a group of outliers for both low-fat and low-carb groups.
Now, as a whole both low-carb and low-fat groups showed similar outcomes. But on an individual level, it showed that while most would lose weight in both groups, there were some outliers who would gain a lot, too.
It is often said that any diet adhered to long enough will result in weight loss. Perhaps this is somewhat of a specious axiom in light of that trial and should be retired. Nevertheless, I have yet to see anyone else discuss those studies and ask the pertinent questions, like, "What could account for the reasons why one person gained weight, while the others lost weight?
Question: Is it possible that what causes one diet to benefit one and not another is directly related to the individual needs based on the microbiotic profile? Is it possible that the outliers in these groups that gained weight in the trial were selected to a group that further decreased Firmicutes or Bacteriodes in individuals who needed to increase those phyla, instead?
If Gary Taubes and Stephan Guyenet argued about the DIETFITS trial, Stephan would probably argue that there is no difference in the diets and talk about calorie-intake (missing the trees for the forest) while Gary would probably focus on the fact that some in the low-fat group gained weight, while the majority of the low-carb group lost weight (missing the forest for the trees). While that's just my speculation, the outcomes have always been fascinating to me.
Another point I’d like to make before my next point (and why I think the insulin-theory is terrible), the insulin production and tested genes had zero impact on predicting weight loss or weight gain outcomes. None. That is not intended as a jab per se to Taubes, I’d just like him to go back to the drawing board to reconcile that information.
In this next section, I'd like to address a few key points of contention that arose between Taubes and Stephan, using some helpful information about the gut microbiome. We understand that:
• The human large intestinal microbiota largely thrives on dietary carbohydrates originating from plant and fungal sources that are indigestible in the upper gut.
• Complex carbohydrates of high molecular weight (HMW) are required to nourish the microbiota of the large intestine. ( Get in-depth info on the importance of molecular weight in prebiotic fibers)
• For some low-carb proponents, despite their low-carbohydrate intake, many continue to gain weight. Perhaps they need to reduce calories (that’s a nod to CICO), or perhaps they needed to increase Firmicutes to improve homeostasis.
• Again, an improvement in the ratio of Firmicutes to Bacteroides species will impact the efficiency of energy extraction, as well as changes in host metabolism, including absorbed calorie potential.
• Some low-carb, high-fat proponents received the help of "safe-starch" promoter Paul Jaminet who showed that feeding gut flora with specific carbohydrates fostered metabolic improvements, and weight loss was experienced.
• Weight loss is associated with lowering the risk of all-cause mortality.
• Systematic reviews also reveal that low-carbohydrate intake is associated with an increased risk of all-cause mortality.
While Systematic reviews suggest that low-carbohydrate diets are associated with an increase in all-cause mortality, the RCTs, Systematic Reviews, and Meta-Analysis involving the full range of benefits associated with a low-carbohydrate ketogenic diet are incredibly compelling. (Here's the research review and summary on the outcomes of all available ketogenic diet RCTs published since 1920 ).
Therefore, there is more that remains to be teased out about low-carbohydrate diets, and to use the systematic reviews that suggest that low-carb diets are associated with an increase in all-cause mortality as a reason to dismiss low-carb or ketogenic diets altogether suggests dogmatic and dichotomous thinking.
Or perhaps sheer ignorance of the studies. That said, the ketogenic diet is not without adverse effects over time, which does indicate to the discerning mind that yet again, more nuance exists and deserves to be teased out accordingly:
• RCTs show that low-carbohydrate diets like the ketogenic diet may be beneficial for up to 8 weeks, however, this benefit diminishes over time, and significantly more adverse effects arise after 8 weeks.
• Perhaps low-carbohydrate and ketogenic diets increase Bacterioidetes and lower Firmicutes, but after 8 weeks of reduced fiber, Firmicutes becomes too low and must be increased for the purposes of maintaining homeostasis.
• Supplementation with specific types of fiber such as medium to HMW soluble carbohydrates, like hydrocolloids may prolong the benefits of a low-carbohydrate or ketogenic diet.
• When starved of complex carbohydrate substrate, the thick mucus that protects the intestines from pathogens can become a substrate for hungry bacteria.
• The hungry bacteria infect the colon wall and increase gut permeability.
• Increased gut permeability leads to the translocation of prolamins and glutelins to organ tissues.
• Low-carbohydrate diets, or simply diets devoid of complex carbohydrates (of varying MW) could be involved in the etiology of autoimmune disease, and other diseases related to increased intestinal permeability.
